Modulation of Vasomotor Function by Perivascular Adipose Tissue of Renal Artery Depends on Severity of Arterial Dysfunction to Nitric Oxide and Severity of Metabolic Parameters

Biomolecules. 2022 Jun 23;12(7):870. doi: 10.3390/biom12070870.

Abstract

Perivascular adipose tissue (PVAT) enhances vascular relaxation of mesenteric arteries in SHRSP.Z-Leprfa/IzmDmcr rats (SPZF), a metabolic syndrome model. We investigated and compared the effects of PVAT on the renal artery in SPZF with those on SHR/NDmcr-cp rats (CP). Renal arteries with and without PVAT were isolated from 23-week-old SPZF and CP. The effects of PVAT on acetylcholine- and nitroprusside-induced relaxation were examined using bioassays with phenylephrine-contracted arterial rings. Acetylcholine-induced relaxations without PVAT in SPZF and CP were 0.7- and 0.5-times lower in females than in males, respectively. In the presence of PVAT, acetylcholine-induced relaxations increased 1.4- and 2-times in male and female CP, respectively, but did not differ in SPZF. Nitroprusside-induced relaxation with and without PVAT was 0.7-times lower in female than in male SPZF but did not differ in CP. Angiotensin-II type-1 receptor (AT1R)/AT1R-associated protein mRNA ratios were lower in CP than in the SPZF and negatively correlated with the difference in arterial relaxation with and without PVAT. The effects of renal artery PVAT differed between the SPZF and CP groups. Higher levels of enhanced AT1R activity in SPZF PVAT may drive these differences by impairing the vascular smooth muscle responses to nitric oxide.

Keywords: adipose tissue; angiotensin II; metabolic syndrome; renal artery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / metabolism
  • Acetylcholine / pharmacology
  • Adipose Tissue / metabolism
  • Animals
  • Female
  • Male
  • Nitric Oxide* / metabolism
  • Nitroprusside / pharmacology
  • Rats
  • Rats, Inbred SHR
  • Receptor, Angiotensin, Type 1 / genetics
  • Renal Artery / metabolism
  • Vasodilation*

Substances

  • Receptor, Angiotensin, Type 1
  • Nitroprusside
  • Nitric Oxide
  • Acetylcholine

Grants and funding

This study was partly supported by JSPS KAKENHI (grant number: JP21K06777 to S.K.).